No Pain More Gain

Description

NPMG Hot Spray is a topical formulation designed for application to the skin. It is characterized by its unique composition, which includes active ingredients that provide a warming sensation upon application. The product is presented in an aerosol dosage form, facilitating even distribution and ease of use. NPMG Hot Spray is formulated to deliver targeted relief to specific areas of the body, making it suitable for various therapeutic applications. The appearance of the spray is clear and colorless, ensuring minimal visibility upon application.

Uses and Indications

This drug is indicated for the relief of local noninflammatory pain. NPMG Hot Spray provides instant pain relief while also moisturizing the skin. Utilizing an advanced German formula, this product begins to work on contact and offers prolonged pain relief for hours. NPMG is designed to penetrate deeply and absorb quickly, delivering a fresh and pleasant scent.

There are no teratogenic or nonteratogenic effects associated with this drug.

Dosage and Administration

Healthcare professionals are advised to administer the medication by spraying a small amount directly onto the affected area. This application may be performed up to four times a day, ensuring that the total number of applications does not exceed this frequency.

It is important to note that this medication is contraindicated for use in children under 12 years of age. After application, healthcare professionals should instruct patients to wash their hands thoroughly to prevent accidental contact with other areas of the body or with other individuals.

Contraindications

There are no specific contraindications listed for this product. However, it is advised to discontinue use and consult a healthcare professional if any of the following occur: worsening of the condition, skin irritation, or if symptoms persist for more than 7 days or resolve and then recur within a few days.

Warnings and Precautions

For external use only. It is imperative to avoid contact with the eyes and mucous membranes to prevent irritation or injury. The product should not be applied to irritated skin, as this may exacerbate the condition. Additionally, the treated area must not be wrapped, bandaged, or subjected to heat from a heating pad, as these actions can lead to increased absorption and potential adverse effects. The product is contraindicated for use on open wounds or broken skin.

Healthcare professionals should advise patients to discontinue use and consult a physician if any of the following occur: worsening of the condition, development of skin irritation, or if symptoms persist for more than 7 days. Patients should also seek medical advice if symptoms resolve and then recur within a few days. Monitoring for these signs is essential to ensure patient safety and effective treatment outcomes.

Side Effects

Patients using this product should be aware of several important warnings and potential adverse reactions. This product is intended for external use only and should not come into contact with the eyes or mucous membranes. It is contraindicated for use on irritated skin, open wounds, or broken skin. Additionally, patients should avoid wrapping, bandaging, or applying a heating pad to the treated area.

In clinical practice, patients are advised to stop using the product and consult a healthcare professional if any of the following occur: worsening of the condition, development of skin irritation, or if symptoms persist for more than 7 days. If symptoms resolve and then recur within a few days, medical advice should also be sought. These precautions are essential to ensure the safe and effective use of the product.

Drug Interactions

No specific drug interactions have been identified for this medication. Additionally, there are no reported interactions with laboratory tests. Therefore, no dosage adjustments or monitoring recommendations are necessary based on drug or laboratory test interactions.

Packaging & NDC

Below are the non-prescription pack sizes of No Pain More Gain (menthol). Columns show Packaging, Formulation Type, and Active Ingredient Strength.

Pediatric Use

Pediatric patients under 12 years of age should not be administered this medication. Safety and efficacy have not been established in this population, and use in this age group is contraindicated.

Geriatric Use

Elderly patients may not have specific information regarding the use of this medication, including dosage adjustments, safety concerns, or special precautions. Therefore, healthcare providers should exercise caution when prescribing this medication to geriatric patients. It is advisable to monitor these patients closely for any potential adverse effects or changes in efficacy, given the lack of targeted data for this population.

Pregnancy

There is no information available regarding the use of NO PAIN MORE GAIN - menthol spray during pregnancy. As such, the safety of this product in pregnant patients has not been established, and there are no known dosage modifications or special precautions recommended for use in this population. Healthcare professionals should exercise caution and consider the potential risks when prescribing this product to women of childbearing potential. It is advisable to weigh the benefits against any unknown risks to fetal outcomes in the absence of specific data.

Lactation

There are no specific warnings or recommendations regarding the use of this product by lactating mothers. Additionally, there is no information available about the potential for excretion in breast milk or any associated risks to breastfed infants.

Renal Impairment

Patients with renal impairment have not been specifically addressed in the available prescribing information. There are no dosage adjustments, special monitoring requirements, or safety considerations outlined for individuals with reduced kidney function. Healthcare professionals should exercise caution and consider the lack of data when prescribing to this patient population.

Hepatic Impairment

Patients with hepatic impairment have not been specifically studied in relation to the use of this medication. Consequently, there are no established dosage adjustments, special monitoring requirements, or precautions outlined for individuals with compromised liver function. It is recommended that healthcare providers exercise caution when prescribing this medication to patients with hepatic impairment, given the lack of data on its safety and efficacy in this population. Regular monitoring of liver function may be prudent in these cases, although specific parameters are not defined in the available information.

Overdosage

In the absence of specific information regarding overdosage, healthcare professionals are advised to exercise caution and adhere to general principles of management in cases of suspected overdose.

It is essential to monitor the patient closely for any potential symptoms that may arise from an overdose. Symptoms can vary widely depending on the substance involved and the individual patient's response.

In the event of an overdose, immediate medical attention should be sought. Healthcare providers should implement supportive care measures, which may include maintaining airway patency, providing supplemental oxygen, and monitoring vital signs.

If available, the use of specific antidotes or treatments should be considered based on the substance involved and the clinical presentation. Consultation with a poison control center or a medical toxicologist may be beneficial in guiding the management of the overdose.

Documentation of the incident, including the substance, amount ingested, time of ingestion, and any symptoms observed, is crucial for effective treatment and follow-up care.

Nonclinical Toxicology

No teratogenic or non-teratogenic effects have been reported in the available nonclinical studies. Additionally, there is no information regarding animal pharmacology and toxicology. The absence of data limits the assessment of potential risks associated with the use of the compound in question. Further studies may be necessary to elucidate these aspects of nonclinical toxicology.

Postmarketing Experience

No postmarketing experience details are available in the insert text.

Patient Counseling

Healthcare providers should advise patients to keep the medication out of reach of children to prevent accidental ingestion or misuse.

Patients should be instructed to stop using the product and consult a doctor if any of the following occur: the condition worsens, skin irritation develops, or if symptoms persist for more than 7 days. Additionally, patients should be informed to seek medical advice if symptoms clear up and then recur within a few days. This guidance is essential to ensure patient safety and effective management of their condition.

Storage and Handling

The product is supplied in a container that must be stored at room temperature. It is essential to protect the container from light exposure to maintain product integrity. The container should be kept tightly closed when not in use to prevent contamination and degradation. Additionally, the product should be discarded after opening to ensure safety and efficacy.

Additional Clinical Information

Patients should apply a small amount of the product directly onto the affected area up to four times a day. Clinicians should advise patients to keep the product out of reach of children and to discontinue use and consult a doctor if the condition worsens, skin irritation occurs, or if symptoms persist for more than 7 days or resolve and then recur within a few days.

Drug Information (PDF)

This file contains official product information for No Pain More Gain, including active ingredients, dosage, warnings, and labeling as submitted by the manufacturer for OTC distribution.

View product document (PDF)